STATEMENT OF COMPLIANCE - East Avenue Medical Center



STATEMENT OF COMPLIANCETERMS OF REFERENCETITLE: Hiring of Consultancy Firm for the Development of National Practice Guidelines for Hematologic Malignancies: Acute Myeloid Leukemia and Diffuse Large B Cell LymphomaTYPE OF CONTRACTOR: Consultancy FirmCLIENT: East Avenue Medical CenterRATIONALEHematologic malignancies, particularly leukemias and Non-Hodgkin Lymphomas, are among the leading cases of cancers in the country. Leukemias are estimated to be the 7th leading cancer site and the 5th cause of death in the country. Among acute leukemias, acute myeloid leukemia (AML) is the most common among adults. Its incidence increases with age with slight male predominance.Non-Hodgkin’s Lymphoma (NHL), on the other hand is estimated to be the 12th leading cancer site and the 11th cause of death in the country. Among the different subtypes, Diffuse Large B Cell Lymphoma (DLBCL) is the most common locally. It has male predominance and incidence increases with age.The Department of Health, in line with Universal Health Care Act and the National Integrated Cancer Control Act, aims to develop national practice guidelines (NPG) in the diagnosis, prognostication and management of hematologic malignancies. This will give patients access to quality and cost-effective healthcare with minimal variations in practice given our available resources. The guidelines are intended for the use of all medical practitioners, allied health professionals, patients and all concerned government agencies.OBJECTIVESACUTE MYELOID LEUKEMIAGENERALTo develop national practice guidelines in the diagnosis and management of acute myeloid leukemia.SPECIFICCreate a multidisciplinary working group for the development of national practice guidelines for acute myeloid leukemia.Conduct evidence-review, appraisal, and synthesis on the diagnosis, prognostication and treatment of acute myeloid leukemia.Conduct public presentation/consultation and submit the final and approved national practice guidelines for acute myeloid leukemia.DIFFUSE LARGE B CELL LYMPHOMAGENERALTo develop national practice guidelines in the diagnosis, staging, prognostication and management of Diffuse Large B Cell Lymphoma.SPECIFICCreate a multidisciplinary working group for the development of national practice guidelines for Diffuse Large B Cell Lymphoma.Conduct evidence-review, appraisal, and synthesis on the diagnosis, staging, prognostication, treatment, and surveillance of Diffuse Large B Cell Lymphoma.Conduct public presentation/consultation and submit the final and approved national practice guidelines for Diffuse Large B Cell Lymphoma.METHODOLOGYThe Consulting Firm should utilize both the WHO and DOH Clinical Practice Guideline Manuals for the Development of the National Practice Guidelines. A combination of adapte and de novo strategies may be utilized to answer the Acute Myeloid Leukemia and Diffuse Large B Cell Leukemia NPG Questions.SCOPE OF WORKThere are two main agencies or institutions involved in the development of national practice guidelines for acute myeloid leukemia and diffuse large B cell lymphoma, the Department of Health and East Avenue Medical Center.The Department of Health shall be the lead convener of the project with oversight functions and the main beneficiary or end-user of the project, and the contractor and funding agency of the project.The East Avenue Medical Center shall assist in identifying and providing subject matter experts to become part of the clinical practice guidelines steering committee and consensus panel.In close coordination with the Department of Health and East Avenue Medical Center, the selected contractual partner shall perform the following activities:Form a multi-disciplinary team of competent professionals with defined roles and responsibilities aligned with the project objectives;Develop a full national practice guidelines protocol to achieve the objectives;Conduct evidence assembly and appraisal, Delphi technique for consultation sessions and other appropriate strategic activities;Conduct alignment meeting with the Department of Health for progress monitoring;Present the final output to the Department of Health and East Avenue Medical Center;Submit approved national practice guidelines in the diagnosis, prognostication and management of acute myeloid leukemia and diffuse large b cell lymphoma with presentation slides in electronic and triplicate hard copies;Provide a financial report to the Department of Health.Approved Budget for the Contract (ABC), Expected Outputs/Deliverables, and Payment SchedulesThe approved budget for the contract (ABC) for the project is TWO MILLION PESOS (?2,000,000.00) inclusive of all taxes, professional fees, and other incidental and administrative costs (i.e. accommodation, transportation, printing and reproduction of reports, supplies and materials for training, workshops, honorarium of steering and consensus committees during meetings, and interviews) chargeable against the funds of the DO 2021-0077 and SAA _____ which the budgeting and auditing guidelines of the government must factor-in in the consultant’s bid price to prevent excessive, unnecessary, and extravagant spending.Expected Outputs/Deliverables and Payment Schedule:ACUTE MYELOID LEUKEMIAACTIVITIESEXPECTED OUTPUT(S)/ DELIVERABLE(S)TIMELINE% PAYMENTAmountFirst Tranche Inception ReportThree (3) hard copies and electronic copy of the Inception Report with the following attachments:Gantt Chart of ActivitiesWork Financial PlanConflict of Interest Declaration FormsMonth 120%200,000.00Agree II Second TrancheEstablishment of the guideline development groupsOrientation of the guideline development groupThree (3) hard copies and electronic copy of the following:Concept note on the establishment of the guideline development groupOrientation presentation deck for the guideline development groupMonths 220%200,000.00Third TrancheGeneration of Research Questions Three (3) hard copies and electronic copy of the following:Concept note on the development and finalization of no more than 15 research questions with the Steering CommitteePresentation deck on the finalization of NPG research questionsMonth 325%250,000.00Fourth TrancheEvidence Gathering, Synthesis, Appraisal and Consensus BuildingThree (3) hard copies and electronic copy of the following:Concept note on the evidence gathering, synthesis, appraisal and consensus buildingPresentation deck on the development and finalization of NPG recommendationsMonth 4-525%250,000.00Fifth TrancheProject Closing and Final CPG RecommendationsThree (3) hard copies and electronic copy of the following:Final project technical and project management reportPhoto-ready NPG recommendationsMonth 610%100,000.00Grand Total6 months100%1,000,000.00DIFFUSE LARGE B CELL LYMPHOMAACTIVITIESEXPECTED OUTPUT(S)/ DELIVERABLE(S)TIMELINE% PAYMENTAmountFirst Tranche Inception ReportThree (3) hard copies and electronic copy of the Inception Report with the following attachments:Gantt Chart of ActivitiesWork Financial PlanConflict of Interest Declaration FormsMonth 120%200,000.00Agree II Second TrancheEstablishment of the guideline development groupsOrientation of the guideline development groupThree (3) hard copies and electronic copy of the following:Concept note on the establishment of the guideline development groupOrientation presentation deck for the guideline development groupMonths 220%200,000.00Third TrancheGeneration of Research Questions Three (3) hard copies and electronic copy of the following:Concept note on the development and finalization of no more than 15 research questions with the Steering CommitteePresentation deck on the finalization of NPG research questionsMonth 325%250,000.00Fourth TrancheEvidence Gathering, Synthesis, Appraisal and Consensus BuildingThree (3) hard copies and electronic copy of the following:Concept note on the evidence gathering, synthesis, appraisal and consensus buildingPresentation deck on the development and finalization of NPG recommendationsMonth 4-525%250,000.00Fifth TrancheProject Closing and Final CPG RecommendationsThree (3) hard copies and electronic copy of the following:Final project technical and project management reportPhoto-ready NPG recommendationsMonth 610%100,000.00Grand Total6 months100%1,000,000.00Payments shall be based on the completion of the above-mentioned activities and submission of required deliverables/reports subject to acceptance of the authorized representative of the Head of the Procuring Entity.The transportation and accommodation of the Consulting Firm and their staff for the period of the contract shall be inclusive.EAMC may allow advance payment to the winning Consulting Firm in the amount, which is not to exceed fifteen percent (15%) of the total contract amount to cover the cost of mobilization, subject to the posting of irrevocable standby letter of credit to be issued by an entity acceptable to the agency and of an amount equal to the advance payment.The mobilization cost shall be repaid by the Consulting Firm by deducting it from their progress payment.The service contract is a fixed price contract. Any extension of contract time shall not involve any additional cost to EAMC.Roles and ResponsibilitiesResponsibilities of EAMCTo provide directions and inputs relevant to the development of CPGTo monitor the work progress of the firmTo assist the firm in the administrative matters pertaining to processing and payment of requirementsResponsibilities of Consulting FirmTo prepare inception report including work plan and time tableTo successfully answer no less than 30 questions (15 questions per section of Blood CPG – AML & DBCL) provided by the EAMC-CPG blood committeeTo conduct series of meetings/consultation sessionsTo provide honorarium for steering and consensus panel during meetings and related activitiesTo present first draft of the CPG to the team for comments/improvementsTo conduct public presentation/consultation among relevant stakeholdersTo submit the approved Hematologic Malignancies (Blood Cancer) clinical practice guidelinesEngagement with Other Institutional PartnersShould the consulting firm engage with other institutional partners, it may do so, provided that DOH and EAMC shall be informed of said engagement in writing and without additional cost on the part of EAMC.Estimated Duration of Engagement and Contract ImplementationThe implementation timeline for the project is six (6) months.Proprietary Rights/OwnershipAll developed NPGs, materials, and references acquired for this project, including digital files, shall be the property of DOH.Subsequent procurement of maintenance and other operating expenses and capital outlay of the Project relative to this project shall be governed by the RA 9184 or the Government Procurement Act, as appropriate.All Intellectual Properties (IPs) resulting from the project shall be owned by both DOH, EAMC and the service provider. The project results, including publication, shall be consistent with R.A. 8393 (Intellectual Property Code of the Philippines) and R.A. 10055 (Technology Transfer Act of 2009).Should the technology/product developed from this project be transferred and commercialized, a separate agreement, consistent with R.A. 10055 and with reference to this agreement, shall be prepared to cover the terms and conditions of technology transfer.EAMC and the consulting firm shall refrain from publishing /presenting /making known to others the results /outputs of the research without prior written approval of all concerned agencies.Qualifications of the Project TeamEAMC shall adopt the Quality Cost Based Evaluation (QCBE) in assessing the competence/qualifications of the Consulting Firm using the following rating: Technical (70%) and Financial (30%). The Consulting Firm must get a score of at least eighty percent (80%) to qualifyCriteria and Rating System for Technical are as follows:CriteriaRatingExperienceRelevant to health/medical researchMore than 3 years (100%)Less than 3 years (50%)Other field of specialization (25%)25%MethodologyClarity, feasibility, innovativeness and comprehensiveness of the plan approach (100%)Quality of interpretation of project problems, risks, and suggested solutions (50%)25%Completed work similar to the ProjectWith 3 or more related projects (100%)With 1 or 2 related projects (50%)No related projects (25%)15%Education of Project LeaderPostgraduate degree Health-related (100%)Postgraduate degree not Health-related (50%)5%Expertise of the Project LeaderSpecialized in the field of public health, health policy, clinical epidemiology, project management (100%)Other specializations (25%)10%10%Expertise of the Personnel involvedWith 3-4 team members, excluding the project leader, specialized in the field of public health, health policy, clinical epidemiology, project management (100%)With 1-2 team members excluding the project leader, specialized in the field of health science, research management, policy development, or health technology assessment (50%)10%Current WorkloadLess than 3 projects (100%)More than 3 projects (50%)10%TOTAL100%Qualifications of the Consulting FirmThe Consulting Firm to be contracted under this TOR should possess the following qualifications:CriteriaRatingHas been in existence for at least three (3) yearsThree (3) years or more (25%)Two (2) years or less (0%)25%Has at least three (3) years of experience in health/medical field, specifically in:Clinical Practice Guidelines and Clinical Pathways (15%)Health Systems and Policy Research (15%)Project Management and Strategic Planning (15%)45%At least three (3) projects completed with similar nature for a Philippine client (either for government or private)Three (3) projects or more (20%)2 projects or less (10%)20%With strong linkages to:Both public and private research institutions and government agencies (10%)Public or private only (5%)10%TOTAL100%Implementation and ArrangementsContact PersonsNilo C. De Los Santos, MDChairman, CPG - Technical Working Group, EAMC+639178959545Allan Troy D. Baquir, MD, MMHOA, FPCSOIC, Chief Medical Professional Services /Head, Professional Educational Training and Research Office+639173074734Mary Claire V. Soliman, MDMember CPG - Technical Working Group, EAMC+639209476292Clarito U. Cairo Jr., MD, FPSVI, FPCOMMedical Officer IV/Program MangerDepartment of Health – Disease Prevention and Control Bureu – Cancer Control Division+639178864045Mark Anthony Cepeda, MDPHILHEALTH - Standards and Monitoring Department+639088962651Project ManagementDr. Nilo De Los Santos is going to manage the contract with the support of Drs. Baquir, Soliman, Cepede and Cairo. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download